TI
RARE icon

Tidal Investments’s Ultragenyx Pharmaceutical RARE Stock Holding History

Tidal Investments’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$242K Buy
+11,563
New +$260K ﹤0.01% 2115
2025
Q4 		– Sell
-11,947
Closed -$359K – 2298
2025
Q3 		$359K Sell
11,947
-644
-5% -$19.3K ﹤0.01% 1745
2025
Q2 		$458K Buy
12,591
+564
+5% +$20.3K ﹤0.01% 1459
2025
Q1 		$435K Sell
12,027
-998
-8% -$41.5K ﹤0.01% 1393
2024
Q4 		$548K Sell
13,025
-658
-5% -$32.6K ﹤0.01% 1331
2024
Q3 		$760K Buy
13,683
+7
+0.1% +$357 0.01% 1150
2024
Q2 		$562K Buy
+13,676
New +$584K 0.01% 1240

Other funds holding RARE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Tidal Investments's RARE Position: Q1 2026 in Review

Tidal Investments opened a new position in Ultragenyx Pharmaceutical (RARE) in Q1 2026: 11,563 shares worth $242K. The stake represents ﹤0.01% of the portfolio and ranks #2115 among its holdings. This is a return to the name: Tidal Investments previously reported a position in RARE as recently as Q3 2025.

Tidal Investments first reported a position in RARE in Q2 2024 and has held it in 7 quarters since. The position peaked at $760K in Q3 2024. 295 funds tracked by Wall St. Rank hold RARE as of Q1 2026.

  • Tidal Investments held 11,563 shares of Ultragenyx Pharmaceutical worth $242K as of Q1 2026.
  • Ultragenyx Pharmaceutical was a new Tidal Investments position in Q1 2026.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Tidal Investments's portfolio in Q1 2026, its #2115 holding.
  • Tidal Investments first reported a position in Ultragenyx Pharmaceutical in Q2 2024 and has held it in 7 quarters since.
  • Tidal Investments's Ultragenyx Pharmaceutical position peaked at $760K in Q3 2024.
  • 295 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.

Based on Tidal Investments's 13F filing for Q1 2026, filed 15 May 2026.